Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:35:05 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Z:BSX - BOSTON SCIENTIFIC CORP - https://www.bsci.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BSX - Z0.148.83·49.450.948.7028.549783    109.4994  47.16509:14:13May 1915 min RT 2¢

Recent Trades - Last 10 of 83
Time ETExPriceChangeVolume
09:14:13Z49.090.391
09:12:24Z49.08750.38751
09:10:23Z49.040.345
09:09:04Z48.890.19200
08:59:59Z48.820.123
08:58:36Z48.8170.1171
08:57:50Z48.820.121
08:49:13Z48.80030.10031
08:49:13Z48.820.128
08:49:13Z48.80030.10038

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-19 06:31U:BSXNews ReleaseFRACTURE IDE trial of the Boston Scientific SEISMIQ(TM) 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
2026-05-18 07:00U:BSXNews ReleaseBoston Scientific enters into $2 billion accelerated share repurchase agreement
2026-05-18 06:30U:BSXNews ReleaseBoston Scientific announces strategic investment in MiRus LLC
2026-05-06 16:05U:BSXNews ReleasePenumbra, Inc. Reports First Quarter 2026 Financial Results
2026-05-04 08:00U:BSXNews ReleaseBoston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
2026-04-26 13:00U:BSXNews ReleaseData at Heart Rhythm 2026 highlight key Boston Scientific therapies
2026-04-22 06:30U:BSXNews ReleaseBoston Scientific announces results for first quarter 2026
2026-04-03 15:24U:BSXNews ReleaseBoston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
2026-03-30 08:00U:BSXNews ReleaseBoston Scientific announces conference call discussing first quarter 2026 results
2026-03-28 10:55U:BSXNews ReleaseCHAMPION-AF study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
2026-03-28 10:38U:BSXNews ReleaseHI-PEITHO trial demonstrates Boston Scientific EKOS(TM) Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
2026-03-06 08:00U:BSXNews ReleaseBoston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology
2026-02-25 13:00U:BSXNews ReleasePenumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-23 08:00U:BSXNews ReleaseBoston Scientific elects Cathy Smith and Christophe Weber to Board of Directors
2026-02-13 08:00U:BSXNews ReleaseBoston Scientific to participate in TD Cowen's 46th Annual Health Care Conference
2026-02-04 06:30U:BSXNews ReleaseBoston Scientific announces results for fourth quarter and full year 2025
2026-01-15 07:00U:BSXNews ReleaseBoston Scientific announces agreement to acquire Penumbra, Inc.
2026-01-12 07:00U:BSXNews ReleaseBoston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
2026-01-02 08:00U:BSXNews ReleaseBoston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
2025-11-03 08:00U:BSXNews ReleaseBoston Scientific announces upcoming investor conference schedule